ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NPCE vs SI // EV/EBITDA & P/E VALUATION

Neuropace Inc. (NASDAQ) VS. Shoulder Innovations Inc. (NYSE) • 15-METRIC TALLY: NPCE 5 — SI 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NPCE VS. SI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NPCE SI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 77.20% 76.50% +0.70 NPCE /gross-margins <GO>
Return on Invested Capital (ROIC) -23.00% -16.10% -6.90 SI /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -2.54% -8.46% +5.92 NPCE /fcf-yield <GO>
Operating Margin -16.30% -55.60% +39.30 NPCE /operating-margins <GO>
Net Profit Margin -21.50% -60.00% +38.50 NPCE /net-margins <GO>
Revenue Growth (YoY) 25.10% 49.60% -24.50 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 8.73 -8.53 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.3 50.8 -11.54 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $446.6M $425.5M $21.0M NPCE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NPCE REV SI REV NPCE GROSS % SI GROSS % NPCE FCF SI FCF
FY 2025 $100.0M $47.3M 77.2% 76.5% -$11.3M -$36.0M
FY 2024 $79.9M $31.6M 73.9% 77.0% -$18.3M -$18.2M
FY 2023 $65.4M — — — -$19.7M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NPCE // BETA —
SI // BETA —